Terumo | 4543 - Cost Of Sales


Terumo reported JPY143.44B in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Astellas Pharma JPY 129.43B 19.7B Mar/2026
Chugai Pharma JPY 92.79B 5.23B Mar/2026
Daiichi Sankyo JPY 118.28B 37.7B Dec/2025
Eisai JPY 51.08B 5.56B Dec/2025
Kyowa Hakko Kirin JPY 37.87B 9.67B Dec/2025
M3 JPY 45.08B 461M Mar/2026
Olympus JPY 96.15B 9.61B Dec/2025
Otsuka Holdings JPY 174.09B 18.65B Mar/2026
Shionogi JPY 25.65B 8.23B Dec/2025
Sumitomo Dainippon JPY 45.59B 1.48B Sep/2025
Takeda JPY 401.15B 184.07B Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025